Related Experiment Video

Updated: May 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Approach to common bacterial infections: community-acquired pneumonia

Pui-Ying Iroh Tam1

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. irohtam@umn.edu

Pediatric Clinics of North America
|March 14, 2013
PubMed

Insights

Community-acquired pneumonia (CAP) is common in young children, but identifying specific pathogens is challenging for antibiotic treatment. Current guidelines recommend amoxicillin for bacterial CAP and azithromycin for atypical CAP in pediatric patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a frequent childhood illness.
  • Identifying specific causative microorganisms in pediatric CAP is difficult, complicating antibiotic selection.
  • Emerging pathogens present ongoing challenges in diagnosing and managing pediatric pneumonia.

Purpose of the Study:

  • To review common and emerging pathogens associated with pediatric CAP.
  • To discuss current guidelines for the management of pediatric CAP.
  • To inform antibiotic strategies for bacterial and atypical pneumonia in children.

Main Methods:

  • Literature review of common and emerging pathogens in pediatric CAP.
  • Analysis of current clinical practice guidelines for pediatric CAP management.
  • Synthesis of information on antibiotic recommendations for different CAP etiologies.

Main Results:

  • High-dose amoxicillin is recommended for bacterial CAP.
  • Azithromycin is recommended for suspected atypical CAP, often caused by Mycoplasma pneumoniae.
  • Accurate pathogen identification remains a challenge in pediatric CAP.

Conclusions:

  • Current guidelines provide a framework for managing pediatric CAP.
  • Amoxicillin and azithromycin remain key antibiotics for specific CAP types.
  • Continued research into pathogen identification and novel treatments is warranted for pediatric pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: